Ignite Creation Date:
2024-05-05 @ 12:01 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00217529
Status:
COMPLETED
Last Update Posted:
2010-09-21
First Post:
2005-09-20
Brief Title:
Erlotinib Docetaxel and Carboplatin in Treating Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial Primary Peritoneal Cavity or Fallopian Tube Cancer
Sponsor:
Fred Hutchinson Cancer Center
Organization:
Fred Hutchinson Cancer Center
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Fallopian Tube Cancer |
| Ovarian Cancer |
| Peritoneal Cavity Cancer |
Keywords:
| Name | View |
|---|---|
| ovarian mixed epithelial carcinoma | View |
| stage III ovarian epithelial cancer | View |
| stage IV ovarian epithelial cancer | View |
| peritoneal cavity cancer | View |
| ovarian clear cell cystadenocarcinoma | View |
| ovarian endometrioid adenocarcinoma | View |
| ovarian undifferentiated adenocarcinoma | View |
| ovarian mucinous cystadenocarcinoma | View |
| ovarian serous cystadenocarcinoma | View |
| Brenner tumor | View |
| fallopian tube cancer | View |